Growth Metrics

Opus Genetics (IRD) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Opus Genetics 357.99 Mn 298.03 Mn - -51.69%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -51.69%
Dec 31, 2025 -32.79%
Sep 30, 2025 -11.03%
Jun 30, 2025 -39.18%
Mar 31, 2025 -13.39%
Dec 31, 2024 -9.62%
Sep 30, 2024 -12.70%
Jun 30, 2024 -18.99%
Mar 31, 2024 0.55%
Dec 31, 2023 44.92%
Sep 30, 2023 -41.68%
Jun 30, 2023 52.11%
Mar 31, 2023 -70.78%
Dec 31, 2022 79.65%
Sep 30, 2022 -23.67%
Jun 30, 2022 -28.08%
Mar 31, 2022 -11.99%
Dec 31, 2021 -6.91%
Sep 30, 2021 5.17%
Jun 30, 2021 0.95%
Mar 31, 2021 -1.24%
Dec 31, 2020 -5.05%
Sep 30, 2020 32.61%
Jun 30, 2020 45.91%
Mar 31, 2020 44.02%
Dec 31, 2019 74.62%
Sep 30, 2019 8.68%
Jun 30, 2019 29.00%
Mar 31, 2019 -7.32%
Dec 31, 2018 -1.51%
Sep 30, 2018 2.56%
Jun 30, 2018 -0.35%
Mar 31, 2018 -11.44%
Dec 31, 2017 -8.74%
Sep 30, 2017 -9.65%
Jun 30, 2017 -11.57%
Mar 31, 2017 -17.38%
Dec 31, 2016 12.80%
Sep 30, 2016 -21.85%
Jun 30, 2016 -26.46%
Mar 31, 2016 -31.81%
Dec 31, 2015 -60.25%
Sep 30, 2015 -40.16%
Jun 30, 2015 -30.57%
Mar 31, 2015 -28.29%
Dec 31, 2014 15.76%
Sep 30, 2014 6.12%
Jun 30, 2014 16.39%
Mar 31, 2014 -2.08%
Dec 31, 2013 2.38%
Sep 30, 2013 -2.77%